Trial intelligence / Profile preview

Early tranexamic acid in multiple trauma patients

IRCT20220507054758N1Phase 3Completed

Sponsor
Zanjan University of Medical Sciences
Start
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in psychological trauma comparing Tranexamic acid with Normal saline placebo (2 arms). Primary endpoints: Mortality, Hemoglobin decrease and 1 more. Started Jun 2022; status: completed.

02

Drugs

tranexamic acid
03

Conditions

psychological trauma

Beyond the preview

Go deeper on IRCT20220507054758N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220507054758N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call